The Epigenetic Landscape of Promoter Genome-wide Analysis in Breast Cancer

Abstract Breast cancer is a heterogeneous disease due to its clinico-pathological features and response to therapy. The classification of breast tumors based on their hormone receptor status and pathologic features. Post-translational histone modifications come into prominence for regulation of gene...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Seher Karsli-Ceppioglu, Aslihan Dagdemir, Gaëlle Judes, André Lebert, Frédérique Penault-Llorca, Yves-Jean Bignon, Dominique Bernard-Gallon
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/f66299dbce164579b210ab05923f1c29
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f66299dbce164579b210ab05923f1c29
record_format dspace
spelling oai:doaj.org-article:f66299dbce164579b210ab05923f1c292021-12-02T16:07:00ZThe Epigenetic Landscape of Promoter Genome-wide Analysis in Breast Cancer10.1038/s41598-017-06790-z2045-2322https://doaj.org/article/f66299dbce164579b210ab05923f1c292017-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-06790-zhttps://doaj.org/toc/2045-2322Abstract Breast cancer is a heterogeneous disease due to its clinico-pathological features and response to therapy. The classification of breast tumors based on their hormone receptor status and pathologic features. Post-translational histone modifications come into prominence for regulation of gene expression in cancer pathogenesis. Here, we analyzed dysregulation of H3K9ac and H3K27me3-enriched subtype-specific genes using ChIP-on-chip assay in breast cancer tumors and matched normal tissue samples. Breast cancer tumors were classified according to St Gallen Consensus 2013. Our results indicated that the promoter regions of genes modified by H3K9ac epi-mark are commonly associated with tumors with HER2-positive and TNBC subtype. H3K27me3-enriched genes were comprised of Luminal A and B1 subtypes. We constructed a network structure to elicit epigenetically regulated genes related with breast cancer progression. The central genes of the network (RUNX1, PAX3, GATA4 and DLX5) were subjected for epigenetically dysregulation in association with different breast cancer subtypes. Our study submits epigenetic mechanisms are crucial to elicit subtype-specific regulation in breast cancer and ChIP-on-chip assay provides a better understanding for breast tumorigenesis and new approaches for prevention and treatment.Seher Karsli-CeppiogluAslihan DagdemirGaëlle JudesAndré LebertFrédérique Penault-LlorcaYves-Jean BignonDominique Bernard-GallonNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-8 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Seher Karsli-Ceppioglu
Aslihan Dagdemir
Gaëlle Judes
André Lebert
Frédérique Penault-Llorca
Yves-Jean Bignon
Dominique Bernard-Gallon
The Epigenetic Landscape of Promoter Genome-wide Analysis in Breast Cancer
description Abstract Breast cancer is a heterogeneous disease due to its clinico-pathological features and response to therapy. The classification of breast tumors based on their hormone receptor status and pathologic features. Post-translational histone modifications come into prominence for regulation of gene expression in cancer pathogenesis. Here, we analyzed dysregulation of H3K9ac and H3K27me3-enriched subtype-specific genes using ChIP-on-chip assay in breast cancer tumors and matched normal tissue samples. Breast cancer tumors were classified according to St Gallen Consensus 2013. Our results indicated that the promoter regions of genes modified by H3K9ac epi-mark are commonly associated with tumors with HER2-positive and TNBC subtype. H3K27me3-enriched genes were comprised of Luminal A and B1 subtypes. We constructed a network structure to elicit epigenetically regulated genes related with breast cancer progression. The central genes of the network (RUNX1, PAX3, GATA4 and DLX5) were subjected for epigenetically dysregulation in association with different breast cancer subtypes. Our study submits epigenetic mechanisms are crucial to elicit subtype-specific regulation in breast cancer and ChIP-on-chip assay provides a better understanding for breast tumorigenesis and new approaches for prevention and treatment.
format article
author Seher Karsli-Ceppioglu
Aslihan Dagdemir
Gaëlle Judes
André Lebert
Frédérique Penault-Llorca
Yves-Jean Bignon
Dominique Bernard-Gallon
author_facet Seher Karsli-Ceppioglu
Aslihan Dagdemir
Gaëlle Judes
André Lebert
Frédérique Penault-Llorca
Yves-Jean Bignon
Dominique Bernard-Gallon
author_sort Seher Karsli-Ceppioglu
title The Epigenetic Landscape of Promoter Genome-wide Analysis in Breast Cancer
title_short The Epigenetic Landscape of Promoter Genome-wide Analysis in Breast Cancer
title_full The Epigenetic Landscape of Promoter Genome-wide Analysis in Breast Cancer
title_fullStr The Epigenetic Landscape of Promoter Genome-wide Analysis in Breast Cancer
title_full_unstemmed The Epigenetic Landscape of Promoter Genome-wide Analysis in Breast Cancer
title_sort epigenetic landscape of promoter genome-wide analysis in breast cancer
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/f66299dbce164579b210ab05923f1c29
work_keys_str_mv AT seherkarsliceppioglu theepigeneticlandscapeofpromotergenomewideanalysisinbreastcancer
AT aslihandagdemir theepigeneticlandscapeofpromotergenomewideanalysisinbreastcancer
AT gaellejudes theepigeneticlandscapeofpromotergenomewideanalysisinbreastcancer
AT andrelebert theepigeneticlandscapeofpromotergenomewideanalysisinbreastcancer
AT frederiquepenaultllorca theepigeneticlandscapeofpromotergenomewideanalysisinbreastcancer
AT yvesjeanbignon theepigeneticlandscapeofpromotergenomewideanalysisinbreastcancer
AT dominiquebernardgallon theepigeneticlandscapeofpromotergenomewideanalysisinbreastcancer
AT seherkarsliceppioglu epigeneticlandscapeofpromotergenomewideanalysisinbreastcancer
AT aslihandagdemir epigeneticlandscapeofpromotergenomewideanalysisinbreastcancer
AT gaellejudes epigeneticlandscapeofpromotergenomewideanalysisinbreastcancer
AT andrelebert epigeneticlandscapeofpromotergenomewideanalysisinbreastcancer
AT frederiquepenaultllorca epigeneticlandscapeofpromotergenomewideanalysisinbreastcancer
AT yvesjeanbignon epigeneticlandscapeofpromotergenomewideanalysisinbreastcancer
AT dominiquebernardgallon epigeneticlandscapeofpromotergenomewideanalysisinbreastcancer
_version_ 1718384816350560256